Optimal Gestational Weight Gain in Obese Moms May Vary

This article originally appeared here.
Share this content:
Optimal Gestational Weight Gain in Obese Moms May Vary
Optimal Gestational Weight Gain in Obese Moms May Vary

FRIDAY, Jan. 23, 2015 (HealthDay News) -- For some obese women, gestational weight gain (GWG) below that recommended in the current guidelines may be advised to reduce the risk of certain adverse pregnancy outcomes, according to research published online Jan. 18 in Obesity Reviews.

Mufiza Zia Kapadia, M.B.B.S., Ph.D., of McMaster University in Hamilton, Canada, and colleagues conducted a systematic review of the literature to assess the risk of adverse pregnancy outcomes associated with GWG below the level recommended in the 2009 Institute of Medicine (IOM) guidelines regarding obese women. The researchers performed a meta-analysis of data from 18 cohort studies.

The researchers found that GWG less than the amount recommended for obese women in the guidelines was associated with higher risk of preterm birth (PTB) (adjusted odds ratio [aOR], 1.46) and small for gestational age (SGA) (aOR, 1.24) and lower risk of large for gestational age (LGA) (aOR, 0.77), compared to GWG within the guidelines. GWG less than the recommended amount for obese women also was associated with lower risk for certain adverse pregnancy outcomes, including macrosomia (aOR, 0.64), gestational hypertension (aOR, 0.70), pre-eclampsia (aOR, 0.90), and cesarean birth (aOR, 0.87).

"In summary, our systematic review indicates that obese pregnant women, who gained below the 5 to 9 kg recommended by the IOM guideline had increased risks for PTB (<37 weeks) and SGA (<10th percentile), but decreased risks for LGA (>90th percentile), macrosomia, gestational hypertension, pre-eclampsia, and cesarean birth," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »